Medgend Icon

Ledgend of Medicine







discontinued


Zetimibe FDA Approved Drugs

EZETIMIBE [EzetimibeC24H21F2NO3]
RX
-
10mg (oral tablet)
Amneal Pharms CoJun 12, 2017
Apotex IncJun 12, 2017
Glenmark Pharms LtdJun 26, 2015
Ohm Labs IncJun 12, 2017
Sandoz IncJun 12, 2017
Teva Pharms UsaJun 12, 2017
Watson Labs IncJun 12, 2017
Zydus Pharms Usa IncJun 12, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EZETIMIBE AND ATORVASTATIN CALCIUM [Atorvastatin Calcium : EzetimibeC24H21F2NO3]
RX
-
eq 10mg base : 10mg (oral tablet)
eq 20mg base : 10mg (oral tablet)
eq 40mg base : 10mg (oral tablet)
eq 80mg base : 10mg (oral tablet)
Watson Labs TevaApr 26, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EZETIMIBE AND SIMVASTATIN [EzetimibeC24H21F2NO3 : SimvastatinC25H38O5]
RX
-
10mg : 10mg (oral tablet)
10mg : 20mg (oral tablet)
10mg : 40mg (oral tablet)
10mg : 80mg (oral tablet)
Dr Reddys Labs SaApr 26, 2017
Impax Labs IncApr 26, 2017
Watson Labs IncApr 26, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VYTORIN [EzetimibeC24H21F2NO3 : SimvastatinC25H38O5]
RX
-
10mg : 10mg (oral tablet)
10mg : 20mg (oral tablet)
10mg : 40mg (oral tablet)
10mg : 80mg (oral tablet)
Msd IntlJul 23, 2004
  • To reduce plasma cholesterol levels in a mammal.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ZETIA [EzetimibeC24H21F2NO3]
RX
-
10mg (oral tablet)
Msd Intl GmbhOct 25, 2002
  • Reduction of elevated plasma sterol and/or stanol levels in a mammal.
  • To reduce elevated total-c, ldl-c, apo b and non-hdl-c in patients with primary hyperlipidemia by administration of ezetimibe alone or in combination with a statin or with fenofibrate.
  • To reduce plasma cholesterol levels in a mammal.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.